David Fleischer, MD

David Fleischer, MD, professor of pediatrics at Children’s Hospital Colorado and global principal investigator of the VITESSE study.

Articles by David Fleischer, MD

How Viaskin could expand options for families managing peanut allergy, with David Fleischer, MD

ByDavid Fleischer, MD

January 7th 2026

According to Fleischer, epicutaneous immunotherapy represents a “marathon, not a sprint,” with potential long-term benefits when started young.

David Fleischer, MD, discusses recent data for Viaskin Peanut patch

ByDavid Fleischer, MD

January 6th 2026

David Fleischer, MD, says phase 3 VITESSE results show the Viaskin peanut patch offers a safe, practical desensitization option for young children with peanut allergy.

David Fleischer, MD

Articles by David Fleischer, MD

How Viaskin could expand options for families managing peanut allergy, with David Fleischer, MD

David Fleischer, MD, discusses recent data for Viaskin Peanut patch

Latest Updated Articles

Trending on Contemporary Pediatrics

CDC changes childhood vaccine schedule, recommends fewer vaccines for all children

FDA accepts Tzield sBLA for stage 2 type 1 diabetes in children as young as 1 year

Reactions to the CDC changing the childhood vaccine schedule

David Fleischer, MD, discusses recent data for Viaskin Peanut patch

PreTRM test and targeted interventions lower preterm birth risks in PRIME trial